Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07094282 · ClinicalTrials.gov registry record · NA

Prospective Assessment of Integrative Therapies for Neuromusculoskeletal Pain (PAIN)

A NA study of Chronic Pain, sponsored by David Moss.

Recruiting
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT07094282: Recruiting NA study of Chronic Pain, sponsored by David Moss.

NCT07094282 is a NA study of Chronic Pain that is actively recruiting participants, run by David Moss. The registered enrollment target is 125 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07094282, a NA study of Chronic Pain, is actively recruiting participants, sponsored by David Moss.

RECRUITING
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

With vast numbers of active-duty members restricted from their specific duties or deemed unfit for deployment because of low back pain, both the mission of the Department of Defense and overall military workflow can be significantly impacted. More than restriction from duty or being barred from deployment, studies have shown musculoskeletal conditions were among the top reasons for medical disability retirement in the Army and Marine Corps (Niebuhr; Sikorski). Given the significant time, money, and resources invested in training these members, each day of inactivity or disability detrimentally affects the execution of the military's mission. Therefore, precise diagnosis and effective treatment modalities are paramount to foster healing and reduce recovery time. From an operational standpoint, the United States Department of Defense (DoD) is specifically interested in using tailored integrative medicine modalities to manage chronic conditions encountered in the military health system. Not just chronic pain, but polytrauma and the triad of conditions it encompasses; traumatic brain injury and post-traumatic stress disorder combined with chronic pain (Madsen, Kim, Bedard). The DoD's goal is also to decrease opioid prescribing and the addiction and altered state associated with opioids. AT the Nellis Integrative Medicine Clinic, physicians, a chiropractor, and nurses are engaged in the treatment of patients. All personnel are trained in the various modalities available in the clinics. A variety of modalities are utilized in the clinic. This prospective study will evaluate the effectiveness of the many modalities used in the Integrative Medicine Clinic (such as acupuncture, myofascial therapies, microcurrent therapies, LASER therapy, extracorporeal shockwave therapy, and pulsed electromagnetic therapies). Most patients receive treatments using multiple modalities. DoD goals align with our experiences in the Integrative Medicine Clinic at Mike O'Callaghan Military Med

Primary Outcome

16 item quality of life questionnaire assessing multiple domains

Conditions Studied

Interventions

  • OTHER Acupuncture
  • OTHER myofascial therapy
  • OTHER microcurrent therapy
  • OTHER LASER
  • OTHER extracorporeal shockwave therapy

Study Locations (1)

Nevada

  • Mike O'Callaghan Military Medical Center - Nellis Air Force Base

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2025-08-04
Est. Completion 2028-07
Phase NA
David Moss

7 total trials

What NCT07094282 shows while recruiting

NCT07094282 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 5 interventions - of which Acupuncture is the first listed.

NCT07094282 reports a single indexed study location in Nevada.

Frequently Asked Questions

What is clinical trial NCT07094282 about?

NCT07094282 is a clinical study titled "Prospective Assessment of Integrative Therapies for Neuromusculoskeletal Pain (PAIN)". With vast numbers of active-duty members restricted from their specific duties or deemed unfit for deployment because of low back pain, both the mission of the Department of Defense and overall military workflow can be significantly impacted. More than restriction from duty or being barred from depl...

What is the current status of trial NCT07094282?

This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2025-08-04. Estimated completion is 2028-07.

What conditions does trial NCT07094282 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT07094282?

The interventions under investigation include: Acupuncture (OTHER), myofascial therapy (OTHER), microcurrent therapy (OTHER), LASER (OTHER), extracorporeal shockwave therapy (OTHER).

Who is sponsoring clinical trial NCT07094282?

This trial is sponsored by David Moss, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07094282 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07094282's enrollment target sits among peer trials

125 116th of 301 higher than 184 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07094282, the US trial registry maintained by the National Library of Medicine. NCT07094282 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.